- Experts Concerned as NIH Axes Critical Vaccine Study Funds
- Brain Implant Lets Woman Talk After 18 Years of Silence Due to Stroke
- Major Job Cuts at NIOSH Pose Risks to Worker Safety, Critics Warn
- Microplastics Linked To High Blood Pressure, Diabetes, Stroke
- Pregnant Women, New Moms Dying More Often From Heart Conditions
- Navigators Help Patients Get Colonoscopy For Suspected Cancer
- GLP-1 Drug Use For Weight Loss Has Soared, Costing Billions
- Fasting Outperforms Calorie Cutting, Clinical Trial Says
- Cardiac Arrest Deaths During Marathons Down By Half
- Local Outbreaks Can Motivate the Vaccine-Hesitant, Poll Finds
CVS Pulling Popular Cold Meds From Shelves After Report Deems Them to Be Useless

CVS Health plans to pull cold medications that contain phenylephrine from its store shelves after federal regulators determined recently that the decongestant doesn’t work.
Oral phenylephrine is an active ingredient in such well-known products as Sudafed and Dayquil. An FDA advisory committee ruled last month that the ingredient was useless in easing congestion.
“We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores,” the company told CBS MoneyWatch.
“Other oral cough and cold products will continue to be offered to meet consumer needs,” the company added.
Another drugstore chain, Walgreens, said it “follows FDA [U.S. Food and Drug Administration] regulations,” but did not say if it would stop selling the medications.
“We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps,” a spokesperson told CBS MoneyWatch.
Medications that contain phenylephrine account for $1.8 billion in annual sales, according to FDA data.
More information
The National Library of Medicine has more on phenylephrine.
SOURCE: CBS News, Oct. 19, 2023
Source: HealthDay
Copyright © 2025 HealthDay. All rights reserved.